SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth
Year: 2017
Type: article
Abstract: , and a potent cytotoxin, auristatin F (AF). The conjugates selectively and potently inhibited proliferation of tumor cells expressing the target integrins. We anticipate that the small molecule-RIP bioconjugate approach can be broadly applied using other small molecule drugs.
Source: Chemical Communications
DOI: 10.1039/c7cc00745k
Institution: Scripps Research Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2596469211
